what's the first dose of tirzepatide Starting Tirzepatide? Here's what you should expect. πΏ few weeks aren't about chasing rapid weight loss they're about helping your body adjust. That's why treatment usually starts with a low Dosing Quick Reference Guide &
Description
SURPASS-CVOT is a large-scale, randomized, double-blind, multinational phase III clinical trial that enrolled 13,299 Type 2 Diabetes Mellitus patients with increased cardiovascular risk
It was historically considered to have minimal therapeutic value in the context of obesity because GIP receptor agonism alone does not produce meaningful weight loss
Common side effects nausea or vomiting, especially during early titration diarrhea or constipation reduced appetite or early fullness Serious but less common pancreatitis or gallbladder inflammation acute kidney injury from dehydration rare allergic reactions When to call your doctor sharp or persistent abdominal pain vomiting that prevents fluid intake swelling, fatigue, or noticeably less urine yellowing of the skin or eye Who Should Not Take Tirzepatide
BENEFITS: Weight loss Neuroprotective Improved fertility Treatment of PCOS Smoking cessation Cardiovascular benefits Improved sleep SIDE EFFECTS: The most commonly reported side effects include nausea, vomiting, diarrhea, stomach pain, appetite loss, and constipation
Remember, this information is for educational purposes and is not a substitute for professional medical advice
